表紙:ヘルスケアの研究開発受託機関市場調査レポート:タイプ別、サービス別、地域別 - 2026年までの世界市場予測 - COVID-19の累積的影響
市場調査レポート
商品コード
1031684

ヘルスケアの研究開発受託機関市場調査レポート:タイプ別、サービス別、地域別 - 2026年までの世界市場予測 - COVID-19の累積的影響

Healthcare Contract Research Organization Market Research Report by Type, by Service, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 193 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=130.29円
ヘルスケアの研究開発受託機関市場調査レポート:タイプ別、サービス別、地域別 - 2026年までの世界市場予測 - COVID-19の累積的影響
出版日: 2021年10月05日
発行: 360iResearch LLP
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のヘルスケアの研究開発受託機関の市場規模は、2020年に410億2,000万米ドルと推定されており、2021年には456億5,000万米ドルに達すると見込まれています。同市場は今後、11.62%のCAGRで拡大し、2026年には793億3,700万米ドルに達すると予測されています。

当レポートでは、ヘルスケアの研究開発受託機関市場について調査し、市場の概要とともに、タイプ別、サービス別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションと範囲
  • 調査対象年
  • 通貨と価格
  • 言語
  • 制限事項
  • 仮定
  • 利害関係者

第2章 調査手法

  • 定義:調査目的
  • 決定:調査デザイン
  • 準備:調査機器
  • 収集:データソース
  • 分析:データの解釈
  • 策定:データ検証
  • 公開:調査レポート
  • 繰り返し:レポートの更新

第3章 エグゼクティブサマリー

第4章 市場概要

  • COVID-19の累積的影響

第5章 市場力学

  • 促進要因
    • 臨床試験中のコストと厳格な規制を軽減するためのアウトソーシング活動に対する高まる傾向
    • 再生医療などの研究開発活動への投資拡大
    • ポートフォリオを拡大することで市場での存在感を高めるためのコラボレーションの増加
  • 抑制要因
    • 熟練した専門家の削減
  • 市場機会
    • バイオシミラーおよび生物製剤セクターからの新たな需要
    • 特殊検査サービスのニーズの高まり
  • 課題
    • ヘルスケアCROサービスの品質問題

第6章 ヘルスケアの研究開発受託機関市場、タイプ別

  • 臨床
    • 第I相治験サービス
    • 第II相治験サービス
    • 第III相治験サービス
    • 第IV相治験サービス
  • 創薬
    • リードの識別
    • リードの最適化
    • ターゲットの検証
  • 前臨床

第7章 ヘルスケアの研究開発受託機関市場、サービス別

  • 生物統計
  • 臨床モニタリング
  • データ管理
  • 治験責任医師への支払い
  • ラボ
  • メディカルライティング
  • 被験者および参加機関の募集
  • プロジェクト管理/臨床供給管理
  • 品質管理/保証
  • 規制/医療
  • 技術

第8章 南北アメリカのヘルスケアの研究開発受託機関市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第9章 アジア太平洋地域のヘルスケアの研究開発受託機関市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ

第10章 欧州、中東・アフリカのヘルスケアの研究開発受託機関市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第11章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • キープレーヤー別市場シェア分析
  • 競合シナリオ
    • 合併と買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 賞、表彰、拡大

第12章 企業のユーザビリティプロファイル

  • Charles River Laboratories, Inc.
  • ClinDatrix, Inc.
  • Covance Inc.
  • Eurofins Scientific SE
  • GVK Biosciences Private Limited.
  • ICON, PLC
  • IQVIA Inc.
  • Medidata Solutions, Inc.
  • Medpace Holdings, Inc.
  • PAREXEL INTERNATIONAL CORPORATION
  • Pharmaceutical Product Development, LLC
  • Pharmaron, Inc.
  • PRA Health Sciences Inc.
  • SGS SA
  • Syneos Health, Inc.
  • Syngene International Limited
  • Wuxi Apptec Co., Ltd.

第13章 付録

  • ディスカッションガイド
  • ライセンスと価格
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2020 VS 2026 (USD BILLION)
  • FIGURE 2. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 3. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: MARKET DYNAMICS
  • FIGURE 4. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 5. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2020 VS 2026 (USD BILLION)
  • FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2026
  • FIGURE 7. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, 2018-2026 (USD BILLION)
  • FIGURE 8. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 9. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE I TRIAL SERVICES, 2018-2026 (USD BILLION)
  • FIGURE 10. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE I TRIAL SERVICES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 11. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE II TRIAL SERVICES, 2018-2026 (USD BILLION)
  • FIGURE 12. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE II TRIAL SERVICES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 13. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE III TRIAL SERVICES, 2018-2026 (USD BILLION)
  • FIGURE 14. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE III TRIAL SERVICES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 15. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE IV TRIAL SERVICES, 2018-2026 (USD BILLION)
  • FIGURE 16. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE IV TRIAL SERVICES, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 17. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, 2018-2026 (USD BILLION)
  • FIGURE 18. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 19. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LEAD IDENTIFICATION, 2018-2026 (USD BILLION)
  • FIGURE 20. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LEAD IDENTIFICATION, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 21. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LEAD OPTIMIZATION, 2018-2026 (USD BILLION)
  • FIGURE 22. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 23. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TARGET VALIDATION, 2018-2026 (USD BILLION)
  • FIGURE 24. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 25. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRE-CLINICAL, 2018-2026 (USD BILLION)
  • FIGURE 26. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRE-CLINICAL, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 27. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2020 VS 2026 (%)
  • FIGURE 28. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2020 VS 2026 (USD BILLION)
  • FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2026
  • FIGURE 30. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIO-STATISTICS, 2018-2026 (USD BILLION)
  • FIGURE 31. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIO-STATISTICS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 32. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL MONITORING, 2018-2026 (USD BILLION)
  • FIGURE 33. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL MONITORING, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 34. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DATA MANAGEMENT, 2018-2026 (USD BILLION)
  • FIGURE 35. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 36. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INVESTIGATOR PAYMENTS, 2018-2026 (USD BILLION)
  • FIGURE 37. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INVESTIGATOR PAYMENTS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 38. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LABORATORY, 2018-2026 (USD BILLION)
  • FIGURE 39. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LABORATORY, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 40. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY MEDICAL WRITING, 2018-2026 (USD BILLION)
  • FIGURE 41. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY MEDICAL WRITING, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 42. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PATIENT AND SITE RECRUITMENT, 2018-2026 (USD BILLION)
  • FIGURE 43. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PATIENT AND SITE RECRUITMENT, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 44. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PROJECT MANAGEMENT/CLINICAL SUPPLY MANAGEMENT, 2018-2026 (USD BILLION)
  • FIGURE 45. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PROJECT MANAGEMENT/CLINICAL SUPPLY MANAGEMENT, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 46. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY QUALITY MANAGEMENT/ ASSURANCE, 2018-2026 (USD BILLION)
  • FIGURE 47. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY QUALITY MANAGEMENT/ ASSURANCE, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 48. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGULATORY/MEDICAL AFFAIRS, 2018-2026 (USD BILLION)
  • FIGURE 49. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGULATORY/MEDICAL AFFAIRS, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 50. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TECHNOLOGY, 2018-2026 (USD BILLION)
  • FIGURE 51. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TECHNOLOGY, BY REGION, 2020 VS 2026 (USD BILLION)
  • FIGURE 52. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 53. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 54. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 55. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 56. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 57. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 58. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 59. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 60. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 61. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 62. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 63. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 64. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 65. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 66. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 67. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 68. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 69. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 70. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 71. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 72. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 73. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 74. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 75. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 76. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 77. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 78. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 79. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 80. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 81. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • FIGURE 82. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: FPNV POSITIONING MATRIX
  • FIGURE 83. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: SHARE, BY KEY PLAYER, 2020
  • FIGURE 84. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 4. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TYPE, 2018-2026 (USD BILLION)
  • TABLE 5. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 6. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE I TRIAL SERVICES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 7. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE II TRIAL SERVICES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 8. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE III TRIAL SERVICES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 9. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PHASE IV TRIAL SERVICES, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 10. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 11. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LEAD IDENTIFICATION, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 12. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 13. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TARGET VALIDATION, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 14. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PRE-CLINICAL, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 15. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY SERVICE, 2018-2026 (USD BILLION)
  • TABLE 16. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY BIO-STATISTICS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 17. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY CLINICAL MONITORING, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 18. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY DATA MANAGEMENT, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 19. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY INVESTIGATOR PAYMENTS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 20. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY LABORATORY, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 21. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY MEDICAL WRITING, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 22. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PATIENT AND SITE RECRUITMENT, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 23. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY PROJECT MANAGEMENT/CLINICAL SUPPLY MANAGEMENT, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 24. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY QUALITY MANAGEMENT/ ASSURANCE, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 25. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY REGULATORY/MEDICAL AFFAIRS, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 26. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, BY TECHNOLOGY, BY REGION, 2018-2026 (USD BILLION)
  • TABLE 27. AMERICAS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 28. ARGENTINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 29. BRAZIL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 30. CANADA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 31. MEXICO HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 32. UNITED STATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 33. ASIA-PACIFIC HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 34. AUSTRALIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 35. CHINA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 36. INDIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 37. INDONESIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 38. JAPAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 39. MALAYSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 40. PHILIPPINES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 41. SINGAPORE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 42. SOUTH KOREA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 43. TAIWAN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 44. THAILAND HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 45. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 46. FRANCE HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 47. GERMANY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 48. ITALY HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 49. NETHERLANDS HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 50. QATAR HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 51. RUSSIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 52. SAUDI ARABIA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 53. SOUTH AFRICA HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 54. SPAIN HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 55. UNITED ARAB EMIRATES HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 56. UNITED KINGDOM HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET SIZE, 2018-2026 (USD BILLION)
  • TABLE 57. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: SCORES
  • TABLE 58. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: BUSINESS STRATEGY
  • TABLE 59. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: PRODUCT SATISFACTION
  • TABLE 60. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: RANKING
  • TABLE 61. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: SHARE, BY KEY PLAYER, 2020
  • TABLE 62. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: MERGER & ACQUISITION
  • TABLE 63. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 64. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 65. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: INVESTMENT & FUNDING
  • TABLE 66. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 67. GLOBAL HEALTHCARE CONTRACT RESEARCH ORGANIZATION MARKET: LICENSE & PRICING
目次
Product Code: MRR-A339DAEFAF94

The Global Healthcare Contract Research Organization Market size was estimated at USD 41.02 billion in 2020 and expected to reach USD 45.65 billion in 2021, at a CAGR 11.62% to reach USD 79.37 billion by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Healthcare Contract Research Organization to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Clinical, Drug Discovery, and Pre-Clinical. The Clinical is further studied across Phase I Trial Services, Phase II Trial Services, Phase III Trial Services, and Phase IV Trial Services. The Drug Discovery is further studied across Lead identification, Lead optimization, and Target validation.

Based on Service, the market was studied across Bio-statistics, Clinical Monitoring, Data Management, Investigator Payments, Laboratory, Medical Writing, Patient and site Recruitment, Project Management/Clinical Supply Management, Quality Management/ Assurance, Regulatory/Medical Affairs, and Technology.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Healthcare Contract Research Organization Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Healthcare Contract Research Organization Market, including Charles River Laboratories, Inc., ClinDatrix, Inc., Covance Inc., Eurofins Scientific SE, GVK Biosciences Private Limited., ICON, PLC, IQVIA Inc., Medidata Solutions, Inc., Medpace Holdings, Inc., PAREXEL INTERNATIONAL CORPORATION, Pharmaceutical Product Development, LLC, Pharmaron, Inc., PRA Health Sciences Inc., SGS SA, Syneos Health, Inc., Syngene International Limited, and Wuxi Apptec Co., Ltd..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Healthcare Contract Research Organization Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Healthcare Contract Research Organization Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Healthcare Contract Research Organization Market?
  • 4. What is the competitive strategic window for opportunities in the Global Healthcare Contract Research Organization Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Healthcare Contract Research Organization Market?
  • 6. What is the market share of the leading vendors in the Global Healthcare Contract Research Organization Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Healthcare Contract Research Organization Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Dynamics

  • 5.1. Introduction
  • 5.2. Drivers
    • 5.2.1. Rising penchant for outsourcing activities to alleviate cost and strict regulations during clinical trials
    • 5.2.2. Growing investments in research and development activities such as regenerative medicine
    • 5.2.3. Increasing collaborations to improve market presence by expanding their portfolio
  • 5.3. Restraints
    • 5.3.1. Reduced skilled professionals
  • 5.4. Opportunities
    • 5.4.1. Emerging demand from biosimilars and biologics sector
    • 5.4.2. Increasing need among specialized testing services
  • 5.5. Challenges
    • 5.5.1. Quality issues of healthcare CRO services

6. Healthcare Contract Research Organization Market, by Type

  • 6.1. Introduction
  • 6.2. Clinical
    • 6.2.1. Phase I Trial Services
    • 6.2.2. Phase II Trial Services
    • 6.2.3. Phase III Trial Services
    • 6.2.4. Phase IV Trial Services
  • 6.3. Drug Discovery
    • 6.3.1. Lead identification
    • 6.3.2. Lead optimization
    • 6.3.3. Target validation
  • 6.4. Pre-Clinical

7. Healthcare Contract Research Organization Market, by Service

  • 7.1. Introduction
  • 7.2. Bio-statistics
  • 7.3. Clinical Monitoring
  • 7.4. Data Management
  • 7.5. Investigator Payments
  • 7.6. Laboratory
  • 7.7. Medical Writing
  • 7.8. Patient and site Recruitment
  • 7.9. Project Management/Clinical Supply Management
  • 7.10. Quality Management/ Assurance
  • 7.11. Regulatory/Medical Affairs
  • 7.12. Technology

8. Americas Healthcare Contract Research Organization Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Healthcare Contract Research Organization Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand

10. Europe, Middle East & Africa Healthcare Contract Research Organization Market

  • 10.1. Introduction
  • 10.2. France
  • 10.3. Germany
  • 10.4. Italy
  • 10.5. Netherlands
  • 10.6. Qatar
  • 10.7. Russia
  • 10.8. Saudi Arabia
  • 10.9. South Africa
  • 10.10. Spain
  • 10.11. United Arab Emirates
  • 10.12. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
    • 11.1.1. Quadrants
    • 11.1.2. Business Strategy
    • 11.1.3. Product Satisfaction
  • 11.2. Market Ranking Analysis
  • 11.3. Market Share Analysis, By Key Player
  • 11.4. Competitive Scenario
    • 11.4.1. Merger & Acquisition
    • 11.4.2. Agreement, Collaboration, & Partnership
    • 11.4.3. New Product Launch & Enhancement
    • 11.4.4. Investment & Funding
    • 11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles

  • 12.1. Charles River Laboratories, Inc.
  • 12.2. ClinDatrix, Inc.
  • 12.3. Covance Inc.
  • 12.4. Eurofins Scientific SE
  • 12.5. GVK Biosciences Private Limited.
  • 12.6. ICON, PLC
  • 12.7. IQVIA Inc.
  • 12.8. Medidata Solutions, Inc.
  • 12.9. Medpace Holdings, Inc.
  • 12.10. PAREXEL INTERNATIONAL CORPORATION
  • 12.11. Pharmaceutical Product Development, LLC
  • 12.12. Pharmaron, Inc.
  • 12.13. PRA Health Sciences Inc.
  • 12.14. SGS SA
  • 12.15. Syneos Health, Inc.
  • 12.16. Syngene International Limited
  • 12.17. Wuxi Apptec Co., Ltd.

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing